Search Results - "beldjilali, Y."

A phase II trial of induction chemotherapy with cisplatin, docetaxel, and capecitabine followed by concurrent cisplatin-radiotherapy in advanced nasopharyngeal carcinoma by Yamouni, M., Beldjilali, Y., Benhadji, K. A., Khellafi, H., Betkaoui, F., Kaid, Y., Benchlef, L., Daim, F. Z., Toubal, S., Boukerche, A., Abdelaoui, A., Djellali, L.

“…Abstract only…”
Get full text

Combination of gemcitabine and carboplatin chemotherapy for recurrent nasopharyngeal carcinoma by Beldjilali, Y., Yamouni, M., Benhadji, K. A., Khellafi, H., Abdelaoui, A., Betkaoui, F., Kaid, A., Daim, F. Z., Benchlef, L., Djellali, L.

“…Abstract only…”
Get full text

Phase II trial of combination docetaxel and cisplatin in patients with locally advanced nasopharyngeal carcinoma by Yamouni, M., Benhadji, K. A., Beldjilali, Y., Lahfa, I., Khellafi, H., Abdelaoui, A., Djellali, L., Bouzid, K.

“…Abstract only 6044 Background: The standard treatment of locally advanced nasopharyngeal carcinoma is cisplatin-based chemotherapy followed by locoregional…”
Get full text

A comparative study of gemcitabine/doxorubicin and cyclophosphamide/doxorubicin combinations in first-line metastatic breast cancer by Beldjilali, Y., Yamouni, M., Benhadji, K. A., Khellafi, H., Abdelaoui, A., Djellali, L.

“…Abstract only…”
Get full text

First results of induction chemotherapy with cisplatin, docetaxel, and capecitabine for the treatment of nasopharyngeal carcinoma by Beldjilali, Y., Benhadji, K. A., Boukerche, A., Khellafi, H., Abdelaoui, A., Betkaoui, F., Tourabi, Z. K., Kaïd, M. Y., Djellali, L., Yamouni, M.

“…Abstract only 6045 Background: The purpose of this phase II study is to assess a new induction chemotherapy regimen combining cisplatin (P), docetaxel (T), and…”
Get full text

A phase II trial of docetaxel and cisplatin combination in patients with locally advanced undifferentiated carcinoma of nasopharyngeal type (UCNT): Study update by Yamouni, M., Benhadji, K. A., Beldjilali, Y., Lahfa, I., Yekrou, D., Djellali, L., Brahimi, M., Bouzid, K.

“…Abstract only 5579 Background: The standard treatment of locally advanced undifferentiated carcinoma of nasopharyngeal type (UCNT) is cisplatin based…”
Get full text

Combination of docetaxel and cisplatin for recurrent nasopharyngeal carcinoma: Preliminary results by Benhadji, K. A., Yamouni, M., Beldjilali, Y., Yekrou, D., Brahimi, M., Chabou, W., Djellali, L.

“…Abstract only…”
Get full text

A phase II trial of docetaxel and cisplatin combination in patients with locally advanced undifferentiated carcinoma of the nasopharynx: updated results by Yamouni, M., Benhadji, K. A., Beldjilali, Y., Lahfa, I., Yekrou, D., Djellali, L., Brahimi, M., Aït-Said, M., Bouzid, K.

“…Abstract only…”
Get full text

Expression C-Kit dans les carcinomes du nasopharynx by Yamouni, M., beldjilali, Y., Belhadji, K., Boukerche, A., Khellafi, H., Abdelaoui, A., Betkaoui, F., Kaïd, A., Madouri, R., Djellali, L.

Get full text